These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10528984)

  • 1. Renal handling of iodobenzoates in rats.
    Laznicek M; Laznickova A
    J Pharm Pharmacol; 1999 Sep; 51(9):1019-23. PubMed ID: 10528984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and elimination of o-125I-benzoate in rats.
    Láznícek M; Kvĕtina J; Srámek B; Kronrád L; Hradílek P
    Gen Physiol Biophys; 1983 Aug; 2(4):279-85. PubMed ID: 6678770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of elimination of o-125I-benzoate in rabbits].
    Richter R; Láznícková A; Láznícek M; Kvĕtina J
    Cesk Farm; 1990 Feb; 39(1):11-4. PubMed ID: 2379243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of inductively coupled plasma mass spectrometry and high-performance liquid chromatography--with parallel electrospray mass spectrometry to the investigation of the disposition and metabolic fate of 2-, 3- and 4-iodobenzoic acids in the rat.
    Jensen BP; Smith CJ; Bailey C; Rodgers C; Wilson ID; Nicholson JK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):279-85. PubMed ID: 15315777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma binding of ortho- and para-I-benzoates on their distribution in blood and into lymph, biotransformation and excretion in rat urine.
    Lamka J; Láznícek M; Gallová S; Rudisar L; Kvĕtina J
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):233-7. PubMed ID: 8149940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the kidney and liver in the total metabolism of (125I) ortho-iodobenzoate in rats].
    Láznícek M; Láznícková A; Kvĕtina J
    Cesk Farm; 1990 Oct; 39(8):353-6. PubMed ID: 2272101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
    Trejtnar F; Laznicek M; Laznickova A; Mather SJ
    J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and elimination of the glycosidase inhibitors 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin in the rat in vivo.
    Faber ED; Oosting R; Neefjes JJ; Ploegh HL; Meijer DK
    Pharm Res; 1992 Nov; 9(11):1442-50. PubMed ID: 1475231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal handling of iodamide and diatrizoate. Evidence of active tubular secretion of iodamide.
    Bollerup AC; Hesse B; Steiness E
    Eur J Clin Pharmacol; 1975 Oct; 9(1):63-7. PubMed ID: 1233254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney and liver contributions to salicylate metabolism in rats.
    Láznícek M; Láznícková A
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):21-6. PubMed ID: 7957447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of dendrimer-based biotin radiopharmaceuticals to enhance whole-body clearance.
    Sato N; Park CW; Kim HS; Han ES; Wong KJ; Paik RS; Park LS; Yao Z; Carrasquillo JA; Paik CH
    Nucl Med Biol; 2003 Aug; 30(6):617-25. PubMed ID: 12900287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of various doses of ionizing radiation on the excretion of 125I-o-iodobenzoic acid and its conjugation products in the rat and the dog.
    Benesová-Půlpánová J; Ledvina M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(2):211-24. PubMed ID: 6596698
    [No Abstract]   [Full Text] [Related]  

  • 13. Prednisolone metabolism and excretion in the isolated perfused rat kidney.
    Rocci ML; Szefler SJ; Acara M; Jusko WJ
    Drug Metab Dispos; 1981; 9(3):177-82. PubMed ID: 6113924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
    Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemical form of the radioactive excretion products after intravenous application of 125I-orthoiodohippurate to rats (author's transl)].
    Bögl W; Stockhausen K
    Nuklearmedizin; 1978 Apr; 17(2):53-6. PubMed ID: 662700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the handling of insulin by the isolated rat kidney.
    Rabkin R; Kitabchi AE
    J Clin Invest; 1978 Jul; 62(1):169-75. PubMed ID: 659630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney.
    Van Crugten JT; Sallustio BC; Nation RL; Somogyi AA
    Drug Metab Dispos; 1991; 19(6):1087-92. PubMed ID: 1687015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.